PNC Financial Services Group Inc. trimmed its holdings in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 23.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,433 shares of the company’s stock after selling 7,035 shares during the quarter. PNC Financial Services Group Inc.’s holdings in BlackRock Health Sciences Term Trust were worth $349,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Invesco Ltd. increased its stake in shares of BlackRock Health Sciences Term Trust by 0.8% during the fourth quarter. Invesco Ltd. now owns 1,543,745 shares of the company’s stock valued at $22,230,000 after buying an additional 11,684 shares during the period. Rockefeller Capital Management L.P. increased its stake in shares of BlackRock Health Sciences Term Trust by 62.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 118,445 shares of the company’s stock valued at $1,706,000 after buying an additional 45,616 shares during the period. Shaker Financial Services LLC purchased a new position in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at $703,000. Alpine Global Management LLC increased its stake in shares of BlackRock Health Sciences Term Trust by 18.8% during the fourth quarter. Alpine Global Management LLC now owns 235,000 shares of the company’s stock valued at $3,384,000 after buying an additional 37,236 shares during the period. Finally, Quarry LP increased its stake in shares of BlackRock Health Sciences Term Trust by 24.7% during the fourth quarter. Quarry LP now owns 109,661 shares of the company’s stock valued at $1,579,000 after buying an additional 21,737 shares during the period.
BlackRock Health Sciences Term Trust Stock Performance
Shares of BlackRock Health Sciences Term Trust stock opened at $14.12 on Friday. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $16.75. The stock’s fifty day moving average price is $14.23 and its 200-day moving average price is $14.66.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What Are the FAANG Stocks and Are They Good Investments?
- 3 Restaurant Stocks That Will Outperform in Q3 and Q4
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- The Midstream Energy Play That Keeps Powering Higher
- How to Calculate Options Profits
- Ethereum Near All-Time High: 3 Stocks Stacking ETH in Treasuries
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.